ARES ACQUISITION CORP II (AACT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AACT • KYG330331045

9.49 USD
+0.61 (+6.87%)
At close: Sep 24, 2025
9.81 USD
+0.32 (+3.37%)
After Hours: 9/24/2025, 8:04:00 PM
Fundamental Rating

1

AACT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. AACT may be in some trouble as it scores bad on both profitability and health. AACT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • AACT had positive earnings in the past year.
  • AACT had a negative operating cash flow in the past year.
AACT Yearly Net Income VS EBIT VS OCF VS FCFAACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

1.2 Ratios

Industry RankSector Rank
ROA 2.91%
ROE 3.06%
ROIC N/A
ROA(3y)2.64%
ROA(5y)N/A
ROE(3y)2.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AACT Yearly ROA, ROE, ROICAACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • AACT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AACT Yearly Profit, Operating, Gross MarginsAACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The number of shares outstanding for AACT remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, AACT has an improved debt to assets ratio.
AACT Yearly Shares OutstandingAACT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
AACT Yearly Total Debt VS Total AssetsAACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 12.91 indicates that AACT is not in any danger for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.02 indicates that AACT is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 12.91
ROIC/WACCN/A
WACCN/A
AACT Yearly LT Debt VS Equity VS FCFAACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • AACT has a Current Ratio of 0.23. This is a bad value and indicates that AACT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AACT has a Quick Ratio of 0.23. This is a bad value and indicates that AACT is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
AACT Yearly Current Assets VS Current LiabilitesAACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • AACT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.98%.
EPS 1Y (TTM)-42.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-94.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 36.50 indicates a quite expensive valuation of AACT.
  • The average S&P500 Price/Earnings ratio is at 27.67. AACT is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 36.5
Fwd PE N/A
AACT Price Earnings VS Forward Price EarningsAACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AACT Per share dataAACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AACT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ARES ACQUISITION CORP II

NYSE:AACT (9/24/2025, 8:04:00 PM)

After market: 9.81 +0.32 (+3.37%)

9.49

+0.61 (+6.87%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-04
Earnings (Next)11-10
Inst OwnersN/A
Inst Owner Change-0.49%
Ins OwnersN/A
Ins Owner Change100%
Market Cap587.05M
Revenue(TTM)N/A
Net Income(TTM)16.33M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 36.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)0.26
EY2.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS8.63
TBVpS8.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.91%
ROE 3.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.64%
ROA(5y)N/A
ROE(3y)2.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z 12.91
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-94.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-457.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.25%
OCF growth 3YN/A
OCF growth 5YN/A

ARES ACQUISITION CORP II / AACT FAQ

What is the fundamental rating for AACT stock?

ChartMill assigns a fundamental rating of 1 / 10 to AACT.


What is the valuation status for AACT stock?

ChartMill assigns a valuation rating of 0 / 10 to ARES ACQUISITION CORP II (AACT). This can be considered as Overvalued.


How profitable is ARES ACQUISITION CORP II (AACT) stock?

ARES ACQUISITION CORP II (AACT) has a profitability rating of 0 / 10.


What is the valuation of ARES ACQUISITION CORP II based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARES ACQUISITION CORP II (AACT) is 36.5 and the Price/Book (PB) ratio is 1.1.